PubRank

F de Vassal

Author PubWeight™ 15.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Demonstration of the efficacy of active immunotherapy in human acute lymphoblastic leukemia]. Rev Fr Etud Clin Biol 1968 1.27
2 Subdivision of classical varieties of acute leukemia. Correlation with prognosis and cure expectancy. Rev Eur Etud Clin Biol 1972 1.01
3 [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)]. Nouv Presse Med 1974 0.99
4 Remission induction with Poly IC in patients with acute lymphoblastic leukaemia (preliminary results). Rev Eur Etud Clin Biol 1970 0.98
5 [Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)]. Nouv Presse Med 1974 0.97
6 [A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)]. Presse Med 1969 0.91
7 Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine. Rev Eur Etud Clin Biol 1971 0.84
8 BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. Natl Cancer Inst Monogr 1973 0.83
9 [The hope of cure of infants with acute lymphoid leukemia. Factors of prognosis at the onset of the disease and their value in therapeutic indications]. Arch Fr Pediatr 1974 0.82
10 New experimental and clinical data on leukaemia immunotherapy. Proc R Soc Med 1975 0.81
11 Vindesine: a new vinca alkaloid. Recent Results Cancer Res 1980 0.79
12 Attempts at stimulation of immune response in acute lymphod leukaemia. Proc R Soc Med 1972 0.79
13 Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapy. Cancer Treat Rep 1978 0.78
14 Phase I-II study of aclarubicin for treatment of acute myeloid leukemia. Cancer Treat Rep 1984 0.78
15 The common acute lymphoid leukemia antigen on b cells of chronic lymphoid leukemia and non-Hodgkin's lymphoma. Biomed Pharmacother 1983 0.77
16 [Allogenic bone marrow graft in man proved by 6 antigenic tracers after conditioning of the receiver and donor by antilymphocyte serum]. Rev Fr Etud Clin Biol 1968 0.77
17 Stored machine-separated lymphocytes in assessing immunodepression. Rev Eur Etud Clin Biol 1972 0.77
18 [Cure expectancy in children with acute lymphoid leukemia (author's transl)]. Folia Clin Int (Barc) 1974 0.75
19 An oriented phase II trial of THP-adriamycin in breast carcinoma. Biomed Pharmacother 1986 0.75
20 [Trial of adriamycin in the treatment of acute leukemia]. Presse Med 1970 0.75
21 [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]. Nouv Presse Med 1978 0.75
22 [Active immunotherapy in acute lymphoid leukemia in children. Influence of several factors on the results]. Arch Fr Pediatr 1973 0.75
23 [Results of 3 protocols of treatment of acute lymphoid leukemia in children]. Arch Fr Pediatr 1978 0.75
24 Immunoblastic acute lymphoid leukaemia. Biomedicine 1974 0.75
25 Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation. Cancer Chemother Pharmacol 1978 0.75
26 [Results of 2 protocols in the treatment of acute lymphoid leukemia in children, according to prognostic factors]. Rev Esp Oncol 1982 0.75
27 New results of active immunotherapy of acute lymphoid leukaemia. Bibl Haematol 1973 0.75
28 Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia. Biomed Pharmacother 1984 0.75
29 [Demonstration of the efficacy of active immunotherapy in acute lymphoblastic human leukemia]. C R Acad Sci Hebd Seances Acad Sci D 1968 0.75
30 [Attempt at treatment of acute leukemias with cytosine-arabinoside according to Skipper's method]. Nouv Rev Fr Hematol 1969 0.75
31 [Classification of the acute leukemias. Therapeutic and prognostic value for acute lymphoid leukemia]. Ann Med Interne (Paris) 1972 0.75
32 Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerism. Transplant Proc 1972 0.75
33 Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas. Cancer Chemother Pharmacol 1979 0.75
34 Phase II trial of active immunotherapy of acute myeloid leukemia. Biomedicine 1975 0.75
35 Cure expectancy in children with acute lymphoid leukemia. J Med Liban 1975 0.75
36 Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorization. Recent Results Cancer Res 1978 0.75
37 [Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route]. Biomed Pharmacother 1982 0.75
38 Chemotherapy with hydroxyurea, leucopheresis and splenectomy in the treatment of chronic myeloid leukemia at the problastic phase. Haematologica 1972 0.75
39 [Acute lymphatic leukemia in children: results of ICIG-ALL protocols 9 and 10, involving respectively short and long chemotherapy before immunotherapy. Identifying two groups of patients according to prognostics]. Nouv Presse Med 1977 0.75
40 A comparative trial of a MAOI, iproniazide, and a polycyclic agent, mianserine, for the search of the most rapidly and frequently active treatment of depressive syndromes in an oncology service. Biomed Pharmacother 1987 0.75
41 Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia. Eur J Haematol Suppl 1987 0.75
42 Cure expectancy in children with acute lymphoid leukemia. Boll Ist Sieroter Milan 1974 0.75
43 [Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)]. Nouv Presse Med 1972 0.75
44 [Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]. Nouv Presse Med 1982 0.75
45 [Hodgkin's disease. Evolution of the concept concerning its natural history and therapeutics. Chemotherapy in the strategy of treatment]. Rev Med Suisse Romande 1972 0.75
46 [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV]. Nouv Presse Med 1975 0.75
47 Splenectomy and karyotypic conversion in chronic myeloid leukaemia. Lancet 1979 0.75
48 [Operational research in anticancer chemotherapy. Chemotherapy and strategy of treatment of cancer]. Bull Mem Soc Med Hop Paris 1968 0.75
49 [Treatment of leukemias and lymphomas by interferons: II. Phase II of the trial treatment of chronic lymphoid leukemia by human interferon alpha+]. Biomed Pharmacother 1982 0.75
50 [Trials of active immunotherapy in acute lymphocytic leukemia. Influence of different factors on results. Study of 100 cases]. Nouv Presse Med 1973 0.75
51 Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma. Recent Results Cancer Res 1980 0.75